Sandoz warns of cheap Chinese imports impacting antibiotic supply

AI Summary

Sandoz's chief executive expressed concerns that inexpensive imports from China could jeopardize Europe’s antibiotic supply. The company emphasized the need for stronger protections to maintain the continent's medicine capacity. Without these measures, there is a risk of significant supply disruptions in a critical healthcare sector. The potential impact on the pharmaceutical market could affect pricing and availability for consumers in Europe.